HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.

AuthorsJeffrey M Weinberg, Elaine C Siegfried
JournalArchives of dermatology (Arch Dermatol) Vol. 142 Issue 5 Pg. 555-8 (May 2006) ISSN: 0003-987X [Print] United States
PMID16702492 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens
  • efalizumab
Topics
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens
  • Child
  • Dermatitis, Atopic (diagnosis, drug therapy, pathology)
  • Diagnosis, Differential
  • Female
  • Humans
  • Injections, Subcutaneous
  • Leg
  • Male
  • Middle Aged
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: